What is the address of Dr. Rudi MEEUSSEN, algemene geneeskunde?

The registered office of Dr. Rudi MEEUSSEN, algemene geneeskunde is located at Costershof 5, 1745 Opwijk.

Is Dr. Rudi MEEUSSEN, algemene geneeskunde still active?

Yes. According to the CBE (22 September 2026) Dr. Rudi MEEUSSEN, algemene geneeskunde is active, legal situation “Normale toestand”, started on 12 October 2007.

Is Dr. Rudi MEEUSSEN, algemene geneeskunde registered on Peppol?

No, Dr. Rudi MEEUSSEN, algemene geneeskunde is currently not registered on the Peppol network.

What is the enterprise number of Dr. Rudi MEEUSSEN, algemene geneeskunde?

The enterprise number of Dr. Rudi MEEUSSEN, algemene geneeskunde is BE0892765828.

When was Dr. Rudi MEEUSSEN, algemene geneeskunde founded?

Dr. Rudi MEEUSSEN, algemene geneeskunde was founded on 12 October 2007.

Who are the directors of Dr. Rudi MEEUSSEN, algemene geneeskunde?

According to the 2025 annual accounts, the directors of Dr. Rudi MEEUSSEN, algemene geneeskunde are: Rudi Meeussen.

Is Dr. Rudi MEEUSSEN, algemene geneeskunde a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 October 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Rudi MEEUSSEN, algemene geneeskunde make in 2025?

Dr. Rudi MEEUSSEN, algemene geneeskunde posted a profit after taxes of € 44,967 in financial year 2025.

What is the revenue of Dr. Rudi MEEUSSEN, algemene geneeskunde?

As a small company, Dr. Rudi MEEUSSEN, algemene geneeskunde is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 96,010.

Dr. Rudi MEEUSSEN, algemene geneeskunde (Private Limited)

Dossier Dr. Rudi MEEUSSEN, algemene geneeskunde, printed on 22 September 2026 from databakkes.be/en/0892765828/dr-rudi-meeussen-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Rudi MEEUSSEN, algemene geneeskunde from Opwijk, company number BE0892765828, closed financial year 2025 with a result of € 44,967 after tax. For that financial year Dr. Rudi MEEUSSEN, algemene geneeskunde recorded a gross margin of € 96,010 and equity of € 153,398. Compared with financial year 2024, the result moved from € 46,029 to € 44,967. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Healthy

€ 153,398

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 44,967

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,857

▼ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 635 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 635

▼ 30% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 23,088

▼ 45% vs 2024

Of which on lease € 21,716.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,658

▼ 36% vs 2024

€ 17,148 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 779

▼ 96% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 35,410

▲ 139% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 50,781 Gross margin 2022: € 50,781 First fiscal year in the series	€ 49,649 Gross margin 2023: € 49,649 ▼ 2% vs 2022 (€ 50,781) Unfavourable step	€ 96,825 Gross margin 2024: € 96,825 ▲ 95% vs 2023 (€ 49,649) Favourable step	€ 96,010 Gross margin 2025: € 96,010 ▼ 1% vs 2024 (€ 96,825) Unfavourable step	▼ 1%
Profit after taxes	€ 17,837 Profit after taxes 2022: € 17,837 First fiscal year in the series	€ 16,945 Profit after taxes 2023: € 16,945 ▼ 5% vs 2022 (€ 17,837) Unfavourable step	€ 46,029 Profit after taxes 2024: € 46,029 ▲ 172% vs 2023 (€ 16,945) Favourable step	€ 44,967 Profit after taxes 2025: € 44,967 ▼ 2% vs 2024 (€ 46,029) Unfavourable step	▼ 2%
Equity	€ 136,600 Equity 2022: € 136,600 First fiscal year in the series	€ 153,545 Equity 2023: € 153,545 ▲ 12% vs 2022 (€ 136,600) Favourable step	€ 158,431 Equity 2024: € 158,431 ▲ 3% vs 2023 (€ 153,545) Favourable step	€ 153,398 Equity 2025: € 153,398 ▼ 3% vs 2024 (€ 158,431) Unfavourable step	▼ 3%
Total debts	€ 158,278 Total debts 2022: € 158,278 First fiscal year in the series	€ 133,557 Total debts 2023: € 133,557 ▼ 16% vs 2022 (€ 158,278) Favourable step	€ 135,178 Total debts 2024: € 135,178 ▲ 1% vs 2023 (€ 133,557) Unfavourable step	€ 89,691 Total debts 2025: € 89,691 ▼ 34% vs 2024 (€ 135,178) Favourable step	▼ 34%
Cash	€ 40,896 Cash 2022: € 40,896 First fiscal year in the series	€ 42,301 Cash 2023: € 42,301 ▲ 3% vs 2022 (€ 40,896) Favourable step	€ 67,995 Cash 2024: € 67,995 ▲ 61% vs 2023 (€ 42,301) Favourable step	€ 47,857 Cash 2025: € 47,857 ▼ 30% vs 2024 (€ 67,995) Unfavourable step	▼ 30%
Land & buildings	€ 38,521 Land & buildings 2022: € 38,521 First fiscal year in the series	€ 44,365 Land & buildings 2023: € 44,365 ▲ 15% vs 2022 (€ 38,521) Unchanged	€ 47,534 Land & buildings 2024: € 47,534 ▲ 7% vs 2023 (€ 44,365) Unchanged	€ 39,787 Land & buildings 2025: € 39,787 ▼ 16% vs 2024 (€ 47,534) Unchanged	▼ 16%
Retained profit	€ 124,200 Retained profit 2022: € 124,200 First fiscal year in the series	€ 141,145 Retained profit 2023: € 141,145 ▲ 14% vs 2022 (€ 124,200) Favourable step	€ 146,031 Retained profit 2024: € 146,031 ▲ 3% vs 2023 (€ 141,145) Favourable step	€ 140,998 Retained profit 2025: € 140,998 ▼ 3% vs 2024 (€ 146,031) Unfavourable step	▼ 3%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 41,143 Dividend 2024: € 41,143 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▲ 22% vs 2024 (€ 41,143) Unchanged	▲ 22%
Bank debt	€ 85,782 Bank debt 2022: € 85,782 First fiscal year in the series	€ 69,197 Bank debt 2023: € 69,197 ▼ 19% vs 2022 (€ 85,782) Favourable step	€ 52,426 Bank debt 2024: € 52,426 ▼ 24% vs 2023 (€ 69,197) Favourable step	€ 33,658 Bank debt 2025: € 33,658 ▼ 36% vs 2024 (€ 52,426) Favourable step	▼ 36%
Balance sheet total	€ 294,878 Balance sheet total 2022: € 294,878 First fiscal year in the series	€ 287,102 Balance sheet total 2023: € 287,102 ▼ 3% vs 2022 (€ 294,878) Unchanged	€ 293,609 Balance sheet total 2024: € 293,609 ▲ 2% vs 2023 (€ 287,102) Unchanged	€ 243,089 Balance sheet total 2025: € 243,089 ▼ 17% vs 2024 (€ 293,609) Unchanged	▼ 17%

Key figures of Dr. Rudi MEEUSSEN, algemene geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Rudi MEEUSSEN, algemene geneeskunde?

What happened at Dr. Rudi MEEUSSEN, algemene geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 44,967 (▼ 2% vs 2024). Source: NBB ↗
Oct 12, 2007 Start of the company according to the CBE. KBO

In short

From € 17,837 profit in 2022 to € 44,967 profit in 2025.

Paid € 55,478 in corporate taxes since 2022.

Best year ever: 2024, with € 46,029 profit.

Paid out € 91,143 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Rudi MEEUSSEN, algemene geneeskunde? We notify you, reason included.

Follow Dr. Rudi MEEUSSEN, algemene geneeskunde

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit